GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Tianyao Pharmaceutical Co Ltd (SHSE:600488) » Definitions » Cyclically Adjusted Revenue per Share

Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Cyclically Adjusted Revenue per Share : ¥2.60 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Tianyao Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Tianjin Tianyao Pharmaceutical Co's adjusted revenue per share for the three months ended in Dec. 2023 was ¥0.859. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥2.60 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Tianjin Tianyao Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Tianjin Tianyao Pharmaceutical Co was 10.10% per year. The lowest was 2.90% per year. And the median was 5.90% per year.

As of today (2024-04-27), Tianjin Tianyao Pharmaceutical Co's current stock price is ¥3.91. Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ¥2.60. Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 1.50.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tianjin Tianyao Pharmaceutical Co was 8.46. The lowest was 1.38. And the median was 2.42.


Tianjin Tianyao Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Tianyao Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Tianjin Tianyao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.08 2.19 2.35 2.46 2.60

Tianjin Tianyao Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.46 2.49 2.52 2.57 2.60

Competitive Comparison of Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Tianjin Tianyao Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tianjin Tianyao Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.859/114.6694*114.6694
=0.859

Current CPI (Dec. 2023) = 114.6694.

Tianjin Tianyao Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.368 98.600 0.428
201406 0.384 98.200 0.448
201409 0.359 98.900 0.416
201412 0.350 99.000 0.405
201503 0.361 99.900 0.414
201506 0.396 99.500 0.456
201509 0.363 100.500 0.414
201512 0.343 100.600 0.391
201603 0.286 102.200 0.321
201606 0.596 101.400 0.674
201609 0.390 102.400 0.437
201612 0.314 102.600 0.351
201703 0.392 103.200 0.436
201706 0.683 103.100 0.760
201709 0.383 104.100 0.422
201712 0.395 104.500 0.433
201803 0.585 105.300 0.637
201806 0.599 104.900 0.655
201809 0.527 106.600 0.567
201812 0.512 106.500 0.551
201903 0.792 107.700 0.843
201906 0.902 107.700 0.960
201909 0.762 109.800 0.796
201912 0.587 111.200 0.605
202003 0.770 112.300 0.786
202006 0.715 110.400 0.743
202009 0.682 111.700 0.700
202012 0.674 111.500 0.693
202103 0.766 112.662 0.780
202106 0.770 111.769 0.790
202109 0.851 112.215 0.870
202112 1.033 113.108 1.047
202203 0.829 114.335 0.831
202206 0.831 114.558 0.832
202209 0.814 115.339 0.809
202212 0.860 115.116 0.857
202303 0.910 115.116 0.906
202306 0.942 114.558 0.943
202309 0.747 115.339 0.743
202312 0.859 114.669 0.859

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Tianjin Tianyao Pharmaceutical Co  (SHSE:600488) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.91/2.6
=1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tianjin Tianyao Pharmaceutical Co was 8.46. The lowest was 1.38. And the median was 2.42.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Tianjin Tianyao Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Tianjin Tianyao Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Business Description

Traded in Other Exchanges
N/A
Address
No. 109 Bawei Road, Hedong District, Tianjin, Tianjin, CHN, 300171
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.

Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Headlines

No Headlines